LETTER TO THE EDITOR
REVISTA DE LA FACULTAD DE MEDICINA HUMANA 2024 - Universidad Ricardo Palma
1 Instituto de Investigaciones de Ciencias Biomédicas, Universidad Ricardo Palma. Lima, Perú.
In response to emerging challenges and societal demands, Universidad Ricardo Palma has reinforced its commitment to research as a fundamental pillar of its institutional policy. Over recent years, Instituto de Investigaciones de Ciencias Biomédicas (INICIB), affiliated with the Rectorate and the Faculty of Human Medicine, has made significant progress, consolidating its contribution to the university's research development.
Research management is a key focus at the Instituto de Investigaciones de Ciencias Biomédicas of
Universidad Ricardo Palma. From the Rectorate and the Vice-Rectorate for Research, clear policies are
established for the development of the research system, the strengthening of productive groups, and the
provision of incentives and stimuli to encourage research and promote the ongoing construction of a
scientific community. It is essential to assess whether the resources allocated to research have a
positive impact on the university, and to quantify and evaluate trends and evolution over time (1).
Recognizing research as a critical axis that drives the quality of higher education, innovation, and
social commitment, this activity has been integrated into our licensing and accreditation processes,
which has positively impacted our university's ranking. Research not only reflects the current state of
the institution but also shapes its future, positioning it as a benchmark in the generation of
intellectual property, knowledge, and human resources that impact educational, scientific, economic, and
social realms (2).
Restrepo & Zabala (2016) state that the challenge for universities is to design clear indicators that
allow for the evaluation of performance and the achievement of their objectives, and that serve to
structure action plans and programs in line with their mission principles. Research, development, and
innovation (R&D&I) activities play a fundamental role in defining competitive strategies for
universities; hence the importance of their appropriate planning, optimal execution, and accurate
measurement (3).
Over the past few years, we have implemented key indicators that have improved decision-making in
management and facilitated a more precise evaluation of our policies, reforms, and academic programs.
The generation of up-to-date and reliable data is now a standard practice at our institute, ensuring
that information serves those responsible for defining and implementing policies that promote robust and
relevant research (4). This approach represents a dynamic process that
includes continuous reevaluation and adaptation to changes in scientific practice and institutional
needs.
These efforts reflect our commitment not only to maintaining but also to continuously improving our
academic and research standards, underscoring the vital role that Universidad Ricardo Palma plays in
advancing science and technology nationally and internationally.
In this editorial, we highlight the performance and achievements reached in thirteen key research
management indicators of the Instituto de Investigaciones de Ciencias Biomédicas of Universidad Ricardo
Palma. The results, covering the year 2023, are organized into five essential categories: A) Human
Resources and Research Lines: Increase in research faculty and greater student participation in
research, with ongoing lines until 2026 (Table 1). B) Infrastructure, Technology, and Budget:
Development of laboratories and advanced technology, with a 100% increase in budget (Table 2). C)
Projects and Publications: Funding for multiple projects and increase in high-impact publications (Table
3). D) Research-Teaching Integration, Events, and Courses: Improvement in the integration of research
and teaching, and the holding of events and training courses (Table 4). E) Student Participation and
Sustained Theses: High student participation in degree courses and an increase in sustained theses
(Table 5). This compendium of indicators and achievements reflects the Institute's commitment to
excellence in research and education, setting a benchmark for future efforts in the biomedical field.
Indicator |
Planned Goals |
Achieved Goals |
Compliance (%) |
Results Analysis |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human Resources |
|||||||||||||||||||
a) Increase in RENACYT-CONCYTEC research professors |
45 medical professors |
>45 medical professors |
>100% Exceeded |
As of December 2023: 60 research professors. |
|||||||||||||||
b) Student participation in research projects |
4 students |
10 students |
>100% Exceeded |
Student participation in various research projects. |
|||||||||||||||
c) Participation of computer science interns |
2 per semester |
2 per semester |
100% Achieved |
Integration of two Computer Engineering interns. |
|||||||||||||||
Priority Research Lines |
|||||||||||||||||||
a) Approved and valid 2021-2026 |
16 lines |
16 lines |
100% Achieved |
Integration of two Computer Engineering interns. |
|||||||||||||||
Research Ethics Committee |
|||||||||||||||||||
a) Research Ethics Committee of the Faculty of Human Medicine |
Valid |
Valid |
100% Achieved |
260 research projects evaluated to date |
Indicator |
Planned Goals |
Achieved Goals |
Compliance (%) |
Results Analysis |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Infrastructure and Technology |
|||||||||||||||||||
a) Development of research laboratories |
3 units |
3 units |
100% Achieved |
Biotechnology Laboratory, Molecular Epidemiology Laboratory, and Cell Culture Laboratory. |
|||||||||||||||
b) State-of-the-art technological equipment |
25 units |
27 units |
>100% Exceeded |
Provision of cutting-edge technology equipment, including an inverted fluorescence microscope, MinION nanopore sequencer, real-time PCR thermocycler, and Qubit fluorometer. |
|||||||||||||||
c) Computer and office equipment |
5 units |
11 units |
>100% Exceeded |
Computer equipment, printers, computers, Wi-Fi internet access, among others. |
|||||||||||||||
d) Platforms and databases |
3 platforms/databases |
3 platforms/databases |
100% Achieved |
Access to Digital Commons |
|||||||||||||||
Research Budget 2023 |
|||||||||||||||||||
a) Budget growth |
25% |
100% |
>100% Exceeded |
Budgets for: |
Indicator |
Planned Goals |
Achieved Goals |
Compliance (%) |
Results Analysis |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Developed Research Projects |
|||||||||||||||||||
a) Projects funded by URP |
10 |
10 |
100% Achieved |
Ten projects funded by URP |
|||||||||||||||
b) Self-funded projects |
15 |
20 |
>100% Exceeded |
Twenty projects completed. |
|||||||||||||||
c) External competitive funds |
1 |
1 |
100% Achieved |
PROCIENCIA-CONCYTEC project for 500,000 soles. |
|||||||||||||||
SCOPUS Scientific Production |
|||||||||||||||||||
a) Growth compared to 2022 |
20% |
>30% |
>100% Exceeded |
As of December 31, 2023, SCOPUS recorded a total of 225 publications affiliated with URP, surpassing the goal. |
|||||||||||||||
b) Substantial increase in Q1-Q2 articles |
5 articles |
>8 articles |
>100% Exceeded |
Presence in Q1-Q2 journals. |
|||||||||||||||
Indexed Scientific Journal |
|||||||||||||||||||
a) Journal of the Faculty of Human Medicine |
4 issues per year |
4 issues per year |
100% Achieved |
Indexed in more than 10 international databases. |
|||||||||||||||
b) Membership in prestigious committees |
1 |
2 |
>100% Exceeded |
Membership was obtained in: |
|||||||||||||||
c) Achieving new indexations |
1 |
4 |
>100% Exceeded |
Dialnet managed by the Dialnet Foundation, Universidad de la Rioja. |
Indicator |
Planned Goals |
Achieved Goals |
Compliance (%) |
Results Analysis |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Participation of Research Professors in Academic Courses |
|||||||||||||||||||
a) Medical course subjects with research professors |
20 |
25 |
>100% Exceeded |
Researchers involved in more than 50% of medical course subjects. |
|||||||||||||||
b) Formative research |
7 |
15 |
>100% Exceeded |
Outputs from formative research (letters to the editor, reviews, articles). |
|||||||||||||||
Organization of Scientific Events |
|||||||||||||||||||
a) International events |
1 |
5 |
>100% Exceeded |
Four conducted events: |
|||||||||||||||
b) National Events |
1 |
2 |
>100% Exceeded |
Two events were conducted: |
|||||||||||||||
c) Participation in international events |
2 |
5 |
>100% Exceeded |
Notable participation in international events: Mexico, Brazil, Italy, Argentina, Spain. |
|||||||||||||||
Research Training |
|||||||||||||||||||
a) Training courses for professors |
2 |
4 |
>100% Exceeded |
Four courses were conducted: |
|||||||||||||||
b) Course for students and professors |
1 |
1 |
100% Achieved |
One course was conducted: |
|||||||||||||||
c) Course for hospital sites |
1 |
2 |
>100% Exceeded |
Two courses were conducted: |
Indicator |
Planned Goals |
Achieved Goals |
Compliance (%) |
Results Analysis |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Students Participating in Thesis Workshop Course |
|||||||||||||||||||
a) Class of 2023 students who attended the workshop |
70% |
98% |
>100% Exceeded |
The number of students exceeded expectations. |
|||||||||||||||
Theses Sustained 2023 |
|||||||||||||||||||
a) Number of theses sustained |
150 |
160 |
>100% Exceeded |
Theses sustained and approved. |
|||||||||||||||
b) Awards for the best theses |
7 |
7 |
100% Achieved |
Economic award and diploma presentation event. |
During 2023, the Instituto de Investigaciones de Ciencias Biomédicas of Universidad Ricardo Palma has
consolidated its research processes, showing significant advances in high-quality scientific production
and in attracting resources for the funding of its research projects, reflecting robust growth in both
areas compared to 2022 (5).
In the realm of scientific production, the indicators reflect sustained growth exceeding the established
goals. According to the SCOPUS index, the growth in scientific output was more than 30%, significantly
surpassing the planned target of 20%. This increase is particularly notable in the publication of
articles in journals categorized within Q1 and Q2 quartiles, where more than eight articles were
published during the year. This achievement emphasizes the international relevance and high impact of
the research conducted at the institute.
Publishing in Q1 and Q2 quartile journals is essential because these represent the most prestigious and
impactful journals in the scientific field. These publications ensure significant visibility within the
international scientific community and contribute decisively to the academic prestige and research
influence of the University. Moreover, such publications are crucial for attracting high-level
collaborations, competitive funding, and top-tier research talent, which are essential for maintaining
and enhancing the quality and innovation in future research projects (6, 7).
Regarding resource acquisition, the institute has stood out for its ability to attract external funding,
as demonstrated by securing a project funded by PROCIENCIA-CONCYTEC with a budget of half a million
soles for a project on inflammatory markers in Peruvian breast cancer patients. For the first time,
INICIB-URP, along with three Oncological Centers in Peru: INEN in Lima, IREN-North in Trujillo, and
IREN-South in Arequipa, are participating collaboratively in this clinical research venture. This
complements the ongoing efforts in self-financing, where twenty projects were completed, five more than
initially projected. Additionally, the research budget grew by more than 100%, far exceeding the 25%
target proposed for 2023. This budgetary growth reflects not only greater investment in infrastructure
and technology but also increased confidence in the institute's capacity to manage and expand its
research effectively (8).
These advancements demonstrate not only the institute's commitment to excellence in research but also
its ability to manage resources that enhance scientific production and technological development. The
ability to exceed goals in scientific production and financial resource acquisition positions the
institute as a leader in biomedical research in the region, with clear positive impacts on academic
training and contribution to global scientific knowledge.
The formulation of standardized measurement indicators for science, technology, and innovation at
international, regional, and institutional levels remains a constant need. In 2022, we proposed the
design of an indicator system tailored to the characteristics of university institutions and the current
trends in the Latin American region. The use and analysis of these indicators allow us to establish
patterns, trends, and regularities in the organization that favor the institutional management of
knowledge about the processes of science, technology, and innovation. Research management is directly
linked to the university's capacity for the generation, dissemination, and evaluation of new knowledge
(9).
This progress is a cornerstone for future initiatives, where the institute is expected to continue
expanding its influence and capacity in scientific research, maintaining its focus on quality and
international relevance of its contributions. Additionally, the solid infrastructure and resources
acquired will enable addressing more complex and competitive scientific challenges at a global level,
ensuring sustainability and continued growth in scientific production and technological innovation.
Correspondence author:
Jhony A. De La Cruz-Vargas.
Address:
INICIB, Facultad de Medicina Humana, Edificio I-208. 2do piso. Avenida Benavides 5440,
Surco, Lima-Perú.
Phone:
708-0000 / Anexo: 6016
E-mail:
jhony.delacruz@urp.edu.pe
Article published by the Journal of the faculty of Human Medicine of the Ricardo Palma University. It is an open access article, distributed under the terms of the Creatvie Commons license: Creative Commons Attribution 4.0 International, CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), that allows non-commercial use, distribution and reproduction in any medium, provided that the original work is duly cited. For commercial use, please contact revista.medicina@urp.edu.pe.